The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism

✍ Scribed by Melanie A. Paquette; Katherine Foley; Elizabeth G. Brudney; Charles K. Meshul; Steven W. Johnson; S. Paul Berger

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 259 KB
• Volume: 204
• Category: Article
• ISSN: 0033-3158
• DOI: 10.1007/s00213-009-1522-7